Gerard Fox

Gerard Fox

AbbVie Inc - Chicago / United States
Others
AD Scientific Index ID: 4399868
-
person_outline Gerard Fox's MOST POPULAR ARTICLES
1-) Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders Molecular interventions 6 (2), 77, 2006
2-) Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup Behavioural Brain Research 131 (1-2), 151-161, 2002
3-) Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl] ethyl}-benzofuran-5-yl) benzonitrile]: II. Neurophysiological characterization and broad preclinical …GB Fox, TA Esbenshade, JB Pan, RJ Radek, KM Krueger, BB Yao, ...Journal of Pharmacology and Experimental Therapeutics 313 (1), 176-190, 20052862005
4-) Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disordersTA Esbenshade, GB Fox, MD CowartMolecular interventions 6 (2), 77, 20062192006
5-) Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pupGB Fox, JB Pan, TA Esbenshade, YL Bennani, LA Black, R Faghih, ...Behavioural Brain Research 131 (1-2), 151-161, 20021822002